Correlation Between Dr Reddys and Viatris

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dr Reddys and Viatris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dr Reddys and Viatris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dr Reddys Laboratories and Viatris, you can compare the effects of market volatilities on Dr Reddys and Viatris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dr Reddys with a short position of Viatris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dr Reddys and Viatris.

Diversification Opportunities for Dr Reddys and Viatris

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between RDY and Viatris is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Dr Reddys Laboratories and Viatris in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viatris and Dr Reddys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dr Reddys Laboratories are associated (or correlated) with Viatris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viatris has no effect on the direction of Dr Reddys i.e., Dr Reddys and Viatris go up and down completely randomly.

Pair Corralation between Dr Reddys and Viatris

Considering the 90-day investment horizon Dr Reddys Laboratories is expected to generate 0.32 times more return on investment than Viatris. However, Dr Reddys Laboratories is 3.08 times less risky than Viatris. It trades about -0.24 of its potential returns per unit of risk. Viatris is currently generating about -0.2 per unit of risk. If you would invest  1,361  in Dr Reddys Laboratories on December 5, 2024 and sell it today you would lose (80.00) from holding Dr Reddys Laboratories or give up 5.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dr Reddys Laboratories  vs.  Viatris

 Performance 
       Timeline  
Dr Reddys Laboratories 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Viatris 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Viatris has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Dr Reddys and Viatris Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dr Reddys and Viatris

The main advantage of trading using opposite Dr Reddys and Viatris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dr Reddys position performs unexpectedly, Viatris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viatris will offset losses from the drop in Viatris' long position.
The idea behind Dr Reddys Laboratories and Viatris pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk